3,5-Bis(trifluoromethyl)benzylamine structure
|
Common Name | 3,5-Bis(trifluoromethyl)benzylamine | ||
---|---|---|---|---|
CAS Number | 85068-29-7 | Molecular Weight | 243.149 | |
Density | 1.4±0.1 g/cm3 | Boiling Point | 165.5±35.0 °C at 760 mmHg | |
Molecular Formula | C9H7F6N | Melting Point | 50-55 °C(lit.) | |
MSDS | Chinese USA | Flash Point | 78.3±0.0 °C | |
Symbol |
GHS05 |
Signal Word | Danger |
Name | 3,5-Bis(trifluoromethyl)benzylamine |
---|---|
Synonym | More Synonyms |
Density | 1.4±0.1 g/cm3 |
---|---|
Boiling Point | 165.5±35.0 °C at 760 mmHg |
Melting Point | 50-55 °C(lit.) |
Molecular Formula | C9H7F6N |
Molecular Weight | 243.149 |
Flash Point | 78.3±0.0 °C |
Exact Mass | 243.048264 |
PSA | 26.02000 |
LogP | 2.51 |
Vapour Pressure | 1.9±0.3 mmHg at 25°C |
Index of Refraction | 1.420 |
Symbol |
GHS05 |
---|---|
Signal Word | Danger |
Hazard Statements | H314 |
Precautionary Statements | P280-P305 + P351 + P338-P310 |
Personal Protective Equipment | Eyeshields;Faceshields;full-face particle respirator type N100 (US);Gloves;respirator cartridge type N100 (US);type P1 (EN143) respirator filter;type P3 (EN 143) respirator cartridges |
Hazard Codes | C:Corrosive; |
Risk Phrases | R21/22;R34 |
Safety Phrases | S26-S36/37/39-S45 |
RIDADR | UN 3259 8/PG 2 |
WGK Germany | 3 |
Packaging Group | III |
Hazard Class | 8 |
HS Code | 2921499090 |
~85% 3,5-Bis(trifluo... CAS#:85068-29-7 |
Literature: EP1500641 A1, ; Page 12 ; |
~99% 3,5-Bis(trifluo... CAS#:85068-29-7 |
Literature: Organic Letters, , vol. 5, # 7 p. 1007 - 1010 |
~92% 3,5-Bis(trifluo... CAS#:85068-29-7 |
Literature: Synlett, , # 10 p. 1623 - 1625 |
~% 3,5-Bis(trifluo... CAS#:85068-29-7 |
Literature: Organic Letters, , vol. 5, # 7 p. 1007 - 1010 |
HS Code | 2921499090 |
---|---|
Summary | 2921499090 other aromatic monoamines and their derivatives; salts thereof VAT:17.0% Tax rebate rate:9.0% Supervision conditions:none MFN tariff:6.5% General tariff:30.0% |
Discovery of 3,5-bis(trifluoromethyl)benzyl L-arylglycinamide based potent CCR2 antagonists.
Bioorg. Med. Chem. Lett. 16(14) , 3735-9, (2006) Systematic modification of a screening lead yielded a class of potent glycinamide based CCR2 antagonists. The best compound (55, (2S)-N-[3,5-bis(trifluoromethyl)benzyl]-2-{[2-(1-piperidinyl)ethyl]amin... |
3,5-Di(trifluoromethyl)benzylamine |
1-[3,5-Bis(trifluoromethyl)phenyl]methanamine |
EINECS 285-290-9 |
Benzenemethanamine, 3,5-bis(trifluoromethyl)- |
FXFFR C1Z EXFFF |
MFCD00009909 |
[3,5-Bis(trifluoromethyl)phenyl]methylamine |
3,5-Bis(trifluoromethyl)benzenemethanamine |
[3,5-Bis(trifluoromethyl)phenyl]methanamine |
3,5-Bis(trifluoromethyl)benzylamine |